Skip to content

Mechanism Study of Zishen Jiangu Formula in Promoting Osteogenesis for Osteoporosis Treatment via Brain-Derived CCN3 Regulation of the PI3K/Akt Pathway?

Mechanism Study of Zishen Jiangu Formula in Promoting Osteogenesis for Osteoporosis Treatment via Brain-Derived CCN3 Regulation of the PI3K/Akt Pathway?

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001785
Enrollment
Unknown
Registered
2025-09-21
Start date
2025-10-08
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

normal group:none

Sponsors

Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: ??Age Requirement??: =45 years old. ??Diagnostic Criteria (based on Dual-Energy X-ray Absorptiometry DXA)??: ??OP Group??: Lumbar spine bone mineral density (BMD) T-score = -2.5 (meeting diagnostic criteria for osteoporosis). ??Normal Group??: Lumbar spine bone mineral density (BMD) T-score > -1.0 (indicating normal bone density). ??Health Status??: Absence of severe cardiac hepatic or renal dysfunction. ??Medication and Medical History??: No other diseases affecting bone metabolism (e.g. thyroid disorders diabetes); No recent use of bone metabolism-related medications (e.g. bisphosphonates).

Exclusion criteria

Exclusion criteria: Inability to cooperate with follow-up or data collection. Any other condition not meeting the inclusion criteria (e.g. failure to satisfy age/diagnostic requirements without repeating specific inclusion criteria).

Design outcomes

Primary

MeasureTime frame
Core pathway indicators (CCN3 concentration, PI3K activity, phosphorylated Akt levels);Osteogenic function marker(Osteocalcin Concentration, Alkaline Phosphatase Activity);bone metabolism (bone mineral density (BMD));

Secondary

MeasureTime frame
Correlation analysis (Pearson correlation coefficient (r value) between CCN3 and PI3K, Akt); Spearman rank correlation coefficient (? value) between CCN3 and osteogenic markers; Linear regression analysis (R ² value) of PI3K/Akt and bone density (T value);Significant difference between groups (mean difference test between 2 groups (independent sample t-test, p<0.05 is significant));

Countries

China

Contacts

Public ContactLin Xiaosheng

Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine?

lxshengtcm@126.com13902908795

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026